SMTL ID : 4c67.1

Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.55 Å

Oligo State

monomer

Ligands

1 x L5S: 13-methyl-7-phenyl-3-thia-1,8,11,12-tetraazatricyclo trideca-2(6),4,7,10,12-pentaene(Non-covalent)

L5S.1: 9 residues within 4Å: Chain A: W.40, P.41, F.42, V.46, L.51, L.53, N.99, I.105, M.108 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:W.40, A:P.41, A:F.42, A:V.46, A:L.51, A:I.105 Hydrogen bonds: A:N.99

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) EDO.3: 5 residues within 4Å: Chain A: I.59, I.60, K.61, T.62, N.94 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:I.59, A:K.61, A:T.62, A:T.62

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mirguet, O. et al., Discovery of Epigenetic Regulator I-Bet762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the Bet Bromodomains. J.Med.Chem. (2013)

Release Date

2013-10-02

Peptides

BROMODOMAIN-CONTAINING PROTEIN 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

BROMODOMAIN-CONTAINING PROTEIN 4

Related Entries With Identical Sequence